An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir

@article{Soliman2018AnUF,
  title={An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir},
  author={M. Soliman and Youssef Soliman and Q. Ahmad and Roopa Yarlagadda},
  journal={Journal of Community Hospital Internal Medicine Perspectives},
  year={2018},
  volume={8},
  pages={167 - 169}
}
  • M. Soliman, Youssef Soliman, +1 author Roopa Yarlagadda
  • Published 2018
  • Medicine
  • Journal of Community Hospital Internal Medicine Perspectives
  • ABSTRACT Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the third highest cause of cancer mortality worldwide. Risk factors include chronic liver disease and cirrhosis of various causes including chronic hepatitis B and C. In cases of chronic hepatitis C virus (HCV), HCC usually does not manifest unless the liver has become cirrhotic. Fortunately, novel treatments for hepatitis C including ledipasvir/sofosbuvir can cure patients from their disease and as a result… CONTINUE READING
    1 Citations

    Paper Mentions

    References

    SHOWING 1-3 OF 3 REFERENCES
    The etiology of hepatocellular carcinoma and consequences for treatment.
    • 388
    • PDF
    Hepatocellular carcinoma in the noncirrhotic liver.
    • 63
    Hepatocellular carcinoma.
    • 7,392
    • PDF